AU Patent

AU2005223736C1 — Prodrugs of piperazine and substituted piperidine antiviral agents

Assigned to ViiV Healthcare UK No 4 Ltd · Expires 2011-10-06 · 15y expired

What this patent protects

This invention provides for prodrug Compounds (I), pharmaceutical compositions thereof, and their use in treating HIV infection. Also, this invention provides for intermediate Compounds (II) useful in making prodrug Compounds (I).

USPTO Abstract

This invention provides for prodrug Compounds (I), pharmaceutical compositions thereof, and their use in treating HIV infection. Also, this invention provides for intermediate Compounds (II) useful in making prodrug Compounds (I).

Drugs covered by this patent

Patent Metadata

Patent number
AU2005223736C1
Jurisdiction
AU
Classification
—
Expires
2011-10-06
Drug substance claim
No
Drug product claim
No
Assignee
ViiV Healthcare UK No 4 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.